Skip to main content

Table 6 Observed and predicted pIC50 values of the training set from the QSAR models

From: In silico insights into the design of novel NR2B-selective NMDA receptor antagonists: QSAR modeling, ADME-toxicity predictions, molecular docking, and molecular dynamics investigations

Compounds Number

Observed pIC50

Pred pIC50 MLR

Pred pIC50 PLSR

Pred pIC50 MNLR

Pred pIC50

CV (LOO)

C1

7.100

7.032

6.652

7.113

6.985

C2

7.100

7.007

6.809

7.089

6.963

C3

7.200

7.229

7.386

7.172

7.246

C5

7.300

6.983

7.166

7.147

6.933

C6

7.600

7.450

7.596

7.561

7.419

C7

7.500

7.303

7.540

7.390

7.240

C8

6.000

5.835

6.267

5.804

5.654

C9

6.000

6.176

6.491

6.229

6.262

C10

7.500

7.569

7.970

7.434

7.623

C11

6.300

6.495

6.645

6.395

6.534

C12

7.800

7.253

7.125

7.239

7.209

C13

6.000

6.079

5.910

5.911

6.108

C14

6.000

6.174

6.259

6.200

6.333

C15

6.000

6.409

6.443

6.279

6.504

C16

6.900

6.715

6.620

6.584

6.690

C17

7.600

7.810

7.631

7.843

7.844

C18

6.600

6.327

6.339

6.621

6.129

C20

6.800

7.129

6.994

7.136

7.190

C21

7.500

7.468

7.363

7.485

7.466

C22

7.900

7.508

7.373

7.539

7.469

C23

7.800

7.874

7.831

7.898

7.888

C25

7.500

7.390

7.255

7.336

7.347

C27

7.200

7.641

7.490

7.591

7.687

C29

7.300

7.364

7.170

7.338

7.370

C31

7.900

7.924

7.684

7.867

7.929

C32

7.300

7.555

7.691

7.496

7.585